发明名称 |
GENETICALLY RECOMBINANT ANTIBODY COMPOSITION CAPABLE OF BINDING SPECIFICALLY TO GANGLIOSIDE GM2 |
摘要 |
<p>The present invention relates to a genetically recombinant antibody composition which specifically binds to ganglioside GM2, which has higher complement-dependent cytotoxic activity than a human IgG1 antibody and a human IgG3 antibody, wherein a polypeptide comprising a CH2 domain in the Fc region of a human TgG1 antibody is replaced by a polypeptide comprising an amino acid sequence which corresponds to the same position of a human IgG3 antibody indicated by the EU index as in Kabat, et al .; a DNA encoding the antibody molecule or a heavy chain constant region of the antibody molecule contained in the recombinant antibody composition; a transformant obtainable by introducing the recombinant vector into a host cell; a process for producing the recombinant antibody composition using the transformant; and a medicament comprising the recombinant antibody composition as an active ingredient.</p> |
申请公布号 |
EP2107115(A1) |
申请公布日期 |
2009.10.07 |
申请号 |
EP20080703821 |
申请日期 |
2008.01.24 |
申请人 |
KYOWA HAKKO KIRIN CO., LTD. |
发明人 |
SHITARA, KENYA;NIWA, RINPEI;NATSUME, AKITO |
分类号 |
C07K16/18;C12N15/09;A61K39/395;A61P35/00;C12N1/15;C12N1/19;C12N5/10;C12P21/08 |
主分类号 |
C07K16/18 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|